Position in JNJ
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$40,232,379
+$26,780,629 QoQ
Shares Held
164,590
+153.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$12,222,000
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Hudson Bay Capital Management LP holds $179,007,948 across 10 Drug Manufacturers - General names. JNJ ranks #2 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,004 | $61,628,269 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
164,590 | $40,232,379 | |
| 3 | BIIB |
Biogen Inc.
|
201,367 | $36,916,612 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
100,010 | $13,938,393 | |
| 5 | MRK |
Merck & Co., Inc.
|
101,505 | $12,210,036 | |
| 6 | NVO |
Novo Nordisk A S
|
125,038 | $4,595,146 | |
| 7 | ABBV |
AbbVie Inc.
|
20,010 | $4,351,974 | |
| 8 | PFE |
Pfizer Inc
|
90,000 | $2,527,200 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,222,000 | 50,000 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $40,232,379 | 164,590 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $13,451,750 | 65,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,193,363 | 6,436 | Shares | Defined | 2025-12-15 | |
| 2025-06-30 | $2,627,300 | 17,200 | Call | Sole | 2025-08-18 | |
| 2025-06-30 | $1,921,595 | 12,580 | Shares | Sole | 2025-08-18 | |
| 2025-06-30 | $10,524,475 | 68,900 | Put | Sole | 2025-08-18 | |
| 2025-03-31 | $54,995,031 | 331,615 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $56,153,424 | 338,600 | Put | Sole | 2025-05-14 | |
| 2024-12-31 | $26,774,946 | 185,140 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $89,943,300 | 555,000 | Shares | Sole | 2024-11-13 | |
| 2024-09-30 | $81,030,000 | 500,000 | Put | Sole | 2024-11-13 | |
| 2024-06-30 | $29,232,000 | 200,000 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $27,039,600 | 185,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $19,773,750 | 125,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,874,650 | 222,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,575,000 | 100,000 | Shares | Sole | 2023-12-07 | |
| 2023-06-30 | $2,482,800 | 15,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $116,250,000 | 750,000 | Put | Sole | 2023-05-16 | |
| 2023-03-31 | $131,750,000 | 850,000 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $123,655,000 | 700,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,168,000 | 50,000 | Shares | Sole | 2022-11-14 | |
| 2020-06-30 | $26,719,700 | 190,000 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||